Not applicableStudy completedNCT02069639
What this trial is testing
TARC After alloSCT in Hodgkin's Lymphoma
Who this might be right for
Hodgkin's Lymphoma Patients Who Underwent an Allogeneic Stem Cell Transplantation
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22